Rapid prototyping enzyme homologs to improve titer of nicotinamide mononucleotide using a strategy combining cell‐free protein synthesis with split GFP

Engineering biological systems to test new pathway variants containing different enzyme homologs is laborious and time‐consuming. To tackle this challenge, a strategy was developed for rapidly prototyping enzyme homologs by combining cell‐free protein synthesis (CFPS) with split green fluorescent protein (GFP). This strategy featured two main advantages: (1) dozens of enzyme homologs were parallelly produced by CFPS within hours, and (2) the expression level and activity of each homolog was determined simultaneously by using the split GFP assay. As a model, this strategy was applied to optimize a 3‐step pathway for nicotinamide mononucleotide (NMN) synthesis. Ten enzyme homologs from different organisms were selected for each step. Here, the most productive homolog of each step was identified within 24 h rather than weeks or months. Finally, the titer of NMN was increased to 1213 mg/L by improving physiochemical conditions, tuning enzyme ratios and cofactor concentrations, and decreasing the feedback inhibition, which was a more than 12‐fold improvement over the initial setup. This strategy would provide a promising way to accelerate design‐build‐test cycles for metabolic engineering to improve the production of desired products.

[1]  Jingwen Zhou,et al.  Systematic Engineering of Escherichia coli for Efficient Production of Nicotinamide Mononucleotide From Nicotinamide. , 2022, ACS synthetic biology.

[2]  K. Jantama,et al.  Synthesis of Nicotinamide Mononucleotide from Xylose via Coupling Engineered Escherichia coli and a Biocatalytic Cascade , 2022, Chembiochem : a European journal of chemical biology.

[3]  Jiang Pan,et al.  Enzymatic synthesis of high-titer nicotinamide mononucleotide with a new nicotinamide riboside kinase and an efficient ATP regeneration system , 2022, Bioresources and Bioprocessing.

[4]  Ashty S. Karim,et al.  Cell-Free Protein Synthesis for High-Throughput Biosynthetic Pathway Prototyping. , 2022, Methods in molecular biology.

[5]  Jiao Feng,et al.  Design of an in vitro multienzyme cascade system for the biosynthesis of nicotinamide mononucleotide , 2022, Catalysis Science & Technology.

[6]  J. Xie,et al.  Multiplexed labeling of cellular proteins with split fluorescent protein tags , 2021, Communications biology.

[7]  Ashty S. Karim,et al.  Toward sustainable, cell-free biomanufacturing. , 2021, Current opinion in biotechnology.

[8]  A. Kondo,et al.  Metabolic design for selective production of nicotinamide mononucleotide from glucose and nicotinamide. , 2020, Metabolic engineering.

[9]  Michael C. Jewett,et al.  In vitro prototyping and rapid optimization of biosynthetic enzymes for cell design , 2020, Nature Chemical Biology.

[10]  D. Sherman,et al.  Multi-component microscale biosynthesis of unnatural cyanobacterial indole alkaloids. , 2020, ACS synthetic biology.

[11]  J. Varner,et al.  The Evolution of Cell Free Biomanufacturing , 2020, Processes.

[12]  Ashty S. Karim,et al.  Total in vitro biosynthesis of the nonribosomal macrolactone peptide valinomycin. , 2020, Metabolic engineering.

[13]  Ashty S. Karim,et al.  Cell-free styrene biosynthesis at high titers , 2020, bioRxiv.

[14]  James U Bowie,et al.  Synthetic Biochemistry: The Bio-inspired Cell-Free Approach to Commodity Chemical Production. , 2020, Trends in biotechnology.

[15]  Yuan Lu.  Cell-Free Synthetic Biology , 2019, SpringerBriefs in Applied Sciences and Technology.

[16]  Ashty S. Karim,et al.  In vitro prototyping of limonene biosynthesis using cell-free protein synthesis , 2020 .

[17]  Jens Nielsen,et al.  Recent trends in metabolic engineering of microbial chemical factories. , 2019, Current opinion in biotechnology.

[18]  Nicole E. Gregorio,et al.  Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology. , 2019, Journal of visualized experiments : JoVE.

[19]  Sanjana Haque,et al.  Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule , 2019, Biomolecules.

[20]  Michael C Jewett,et al.  Cell-free biosynthesis of limonene using enzyme-enriched Escherichia coli lysates , 2019, Synthetic biology.

[21]  Bradley C. Bundy,et al.  Cell-free biomanufacturing , 2018, Current Opinion in Chemical Engineering.

[22]  A. Dinischiotu,et al.  β-nicotinamide mononucleotide (NMN) production in Escherichia coli , 2018, Scientific Reports.

[23]  Paul S. Freemont,et al.  Rapid acquisition and model-based analysis of cell-free transcription–translation reactions from nonmodel bacteria , 2018, Proceedings of the National Academy of Sciences.

[24]  Ashty S Karim,et al.  Cell-Free Synthetic Biology for Pathway Prototyping. , 2018, Methods in enzymology.

[25]  T. Roberts,et al.  Synthetic Biology for Cell-Free Biosynthesis: Fundamentals of Designing Novel In Vitro Multi-Enzyme Reaction Networks. , 2018, Advances in biochemical engineering/biotechnology.

[26]  Richard J. R. Kelwick,et al.  Cell-free prototyping strategies for enhancing the sustainable production of polyhydroxyalkanoates bioplastics , 2017, bioRxiv.

[27]  Tong Un Chae,et al.  Recent advances in systems metabolic engineering tools and strategies. , 2017, Current opinion in biotechnology.

[28]  Song-Min Schinn,et al.  Rapid in vitro screening for the location-dependent effects of unnatural amino acids on protein expression and activity. , 2017, Biotechnology and bioengineering.

[29]  K. Jaeger,et al.  Activity-independent screening of secreted proteins using split GFP. , 2017, Journal of biotechnology.

[30]  J. Martinussen,et al.  Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance , 2016, Microbiology and Molecular Biology Reviews.

[31]  K. Tsubota,et al.  NAMPT-Mediated NAD(+) Biosynthesis Is Essential for Vision In Mice. , 2016, Cell reports.

[32]  Michael C Jewett,et al.  Cell-Free Mixing of Escherichia coli Crude Extracts to Prototype and Rationally Engineer High-Titer Mevalonate Synthesis. , 2016, ACS synthetic biology.

[33]  Tahira Bibi,et al.  Pcal_1127, a highly stable and efficient ribose-5-phosphate pyrophosphokinase from Pyrobaculum calidifontis , 2016, Extremophiles.

[34]  Yinjie J. Tang,et al.  Metabolic Burden: Cornerstones in Synthetic Biology and Metabolic Engineering Applications. , 2016, Trends in biotechnology.

[35]  Ashty S Karim,et al.  A cell-free framework for rapid biosynthetic pathway prototyping and enzyme discovery. , 2016, Metabolic engineering.

[36]  Luke A. Gilbert,et al.  Versatile protein tagging in cells with split fluorescent protein , 2016, Nature Communications.

[37]  J. Keasling,et al.  Engineering Cellular Metabolism , 2016, Cell.

[38]  U. Bornscheuer,et al.  In-Depth High-Throughput Screening of Protein Engineering Libraries by Split-GFP Direct Crude Cell Extract Data Normalization. , 2015, Chemistry & biology.

[39]  Ashty S. Karim,et al.  Cell‐free metabolic engineering: Biomanufacturing beyond the cell , 2015, Biotechnology journal.

[40]  Tiangang Liu,et al.  In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli , 2014, Biotechnology and bioengineering.

[41]  Vincent Noireaux,et al.  Linear DNA for rapid prototyping of synthetic biological circuits in an Escherichia coli based TX-TL cell-free system. , 2014, ACS synthetic biology.

[42]  J. Liao,et al.  Synthetic non-oxidative glycolysis enables complete carbon conservation , 2013, Nature.

[43]  Ron Milo,et al.  eQuilibrator—the biochemical thermodynamics calculator , 2011, Nucleic Acids Res..

[44]  S. Imai,et al.  Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.

[45]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[46]  H. Osago,et al.  Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma , 2011, PloS one.

[47]  C. Miao,et al.  A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase. , 2011, Analytical biochemistry.

[48]  Michael C Jewett,et al.  An integrated cell-free metabolic platform for protein production and synthetic biology , 2008, Molecular systems biology.

[49]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[50]  Radhey S. Gupta,et al.  Identification and characterization of human ribokinase and comparison of its properties with E. coli ribokinase and human adenosine kinase , 2007, FEBS letters.

[51]  G. Waldo,et al.  In vivo and in vitro protein solubility assays using split GFP , 2006, Nature Methods.

[52]  T. Terwilliger,et al.  Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein , 2005, Nature Biotechnology.

[53]  M. Jewett,et al.  Mimicking the Escherichia coli cytoplasmic environment activates long‐lived and efficient cell‐free protein synthesis , 2004, Biotechnology and bioengineering.

[54]  R. Gupta,et al.  The Effect of Inorganic Phosphate on the Activity of Bacterial Ribokinase , 2001, Journal of protein chemistry.

[55]  R. Switzer,et al.  Overexpression, purification, and characterization of recombinant human 5-phosphoribosyl-1-pyrophosphate synthetase isozymes I and II. , 1993, The Journal of biological chemistry.

[56]  I. Ichikizaki,et al.  Synthesis of Nicotinamide. , 1954 .